Cairo - Mubasher: The consolidated financial results of Minapharm Pharmaceuticals showed a 19.45% hike in net profits to EGP 148.41 million during the first quarter (Q1) of 2020, compared to EGP 124.24 million in the same period of 2019.
The company's sales rose to EGP 2.051 million in Q1-2020 from EGP 1.919 million in the year-ago period, according to the company's disclosure to the Egyptian Stock Exchange (EGX) on Monday.
In 2019, the company's net profits declined by 36% year-on-year (YoY) to EGP 46.035 million from EGP 72.12 million in 2018.
All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).